Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy C Sherman

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Open Forum Infectious Diseases|June 4, 2026
Invasive Fungal Sinusitis in Patients With Hematological Malignancies: A 20-Year Study From a Tertiary Academic US Hospital SystemTejas S Athni, Carolyn B Strauch, Victor Kovac, et al.
Clinical Biochemistry|March 6, 2023
Lessons learned: A look back at the performance of nine COVID-19 serologic assays and their proposed utilityNicole V Tolan, Mia S DeSimone, Maria D Fernandes, et al.
Infection Control and Hospital Epidemiology|February 9, 2021
Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A cross-sectional analysis of subjects enrolled in the COVID-19 Prevention in Emory Healthcare Personnel (COPE) studyJessica R Howard-Anderson, Carly Adams, Amy C Sherman, et al.
Microbiology Spectrum|March 21, 2022
The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine RecipientsNicole V Tolan, Amy C Sherman, Guohai Zhou, et al.
Blood Advances|August 13, 2021
Activity of mRNA COVID-19 vaccines in patients with lymphoid malignanciesJennifer L Crombie, Amy C Sherman, Chi-An Cheng, et al.
Vaccine|June 11, 2024
Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine seriesAmy C Sherman, Simon D van Haren, Ella Borberg, et al.
Open Forum Infectious Diseases|August 31, 2022
Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid MalignanciesAmy C Sherman, Jennifer L Crombie, ChiAn Cheng, et al.
Infection Control and Hospital Epidemiology|February 14, 2022
Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A 6-month prospective analysis of the COVID-19 Prevention in Emory Healthcare Personnel (COPE) StudyJessica R Howard-Anderson, Carly Adams, William C Dube, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|July 17, 2025
Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection or Disease or with Concurrent Organ Dysfunction: A Phase 2 Open Label StudyMatthew P Cheng, Isabel H Gonzalez-Bocco, Esther Arbonna-Haddad, et al.
Blood|May 12, 2023
Immunogenicity of quadrivalent meningococcal conjugate vaccine in frequent platelet donorsMichaël Desjardins, Phoebe Cunningham, Xhoi Mitre, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Open Forum Infectious Diseases|June 4, 2026
Invasive Fungal Sinusitis in Patients With Hematological Malignancies: A 20-Year Study From a Tertiary Academic US Hospital SystemTejas S Athni, Carolyn B Strauch, Victor Kovac, et al.
Clinical Biochemistry|March 6, 2023
Lessons learned: A look back at the performance of nine COVID-19 serologic assays and their proposed utilityNicole V Tolan, Mia S DeSimone, Maria D Fernandes, et al.
Infection Control and Hospital Epidemiology|February 9, 2021
Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A cross-sectional analysis of subjects enrolled in the COVID-19 Prevention in Emory Healthcare Personnel (COPE) studyJessica R Howard-Anderson, Carly Adams, Amy C Sherman, et al.
Microbiology Spectrum|March 21, 2022
The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine RecipientsNicole V Tolan, Amy C Sherman, Guohai Zhou, et al.
Blood Advances|August 13, 2021
Activity of mRNA COVID-19 vaccines in patients with lymphoid malignanciesJennifer L Crombie, Amy C Sherman, Chi-An Cheng, et al.
Vaccine|June 11, 2024
Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine seriesAmy C Sherman, Simon D van Haren, Ella Borberg, et al.
Open Forum Infectious Diseases|August 31, 2022
Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid MalignanciesAmy C Sherman, Jennifer L Crombie, ChiAn Cheng, et al.
Infection Control and Hospital Epidemiology|February 14, 2022
Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A 6-month prospective analysis of the COVID-19 Prevention in Emory Healthcare Personnel (COPE) StudyJessica R Howard-Anderson, Carly Adams, William C Dube, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|July 17, 2025
Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection or Disease or with Concurrent Organ Dysfunction: A Phase 2 Open Label StudyMatthew P Cheng, Isabel H Gonzalez-Bocco, Esther Arbonna-Haddad, et al.
Blood|May 12, 2023
Immunogenicity of quadrivalent meningococcal conjugate vaccine in frequent platelet donorsMichaël Desjardins, Phoebe Cunningham, Xhoi Mitre, et al.
Pageof 6